Aarti Industries Q1 FY27 Earnings Call — Analysis (NSE: AARTIIND)
Aarti Industries posted strong Q1FY27 revenue of ₹2,627 Cr (+41% YoY) and EBITDA of ₹385 Cr (+79% YoY), boosted by product mix and inventory gains, but Zone 4 project delayed 3-6 months and Middle East conflict hit energy exports.
The take
Q1FY27 Revenue ₹2,627 Cr ( +41% YoY ) . New guidance — Q2FY27 augene jv commissioning and rev… ₹300-400 Cr . New story: Capacity expansion and capex cycle peaking .
Results
Revenue ₹2,627 Cr +41% YoY; EBITDA ₹385 Cr +79% YoY; PAT ₹155 Cr +260% YoY.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹2,627 Cr | +41% | yoy · Q1FY27 |
| EBITDA | ₹385 Cr | +79% | yoy · Q1FY27 |
| PAT | ₹155 Cr | +260% | yoy · Q1FY27 |
| Capex deployed in Q1 | ₹180 Cr | point_in_time · Q1FY27 · Q1FY27 |
Guidance
FY28 EBITDA aspiration of ₹1,800 Cr maintained despite Zone 4 delay; FY27 capex on track at ₹700-800 Cr; Augene JV commissioning in Q2FY27.
What management committed to
- Aarti Industries' FY27 CAPEX remains on track within the Rs. 700 to 800 crore range. — Rs. 700 to 800 crore, FY27
- [Aarti Industries] expects Zone 4 project to be commissioned in a phased manner in FY27, with ramp-up over FY28 and FY29. — FY27
- The Augene Chemicals JV will commission in Q2FY27 and reach decent utilization in 1-2 years, with steady-state revenue of ₹300-400 Crore. — ₹300-400 Crore, Q2FY27
- Aarti Circularity plastic recycling JV will commission in the second half of FY27. — H2FY27
- [Aarti Industries] will debottleneck DCB capacity to 140 KTPA backed by volume increase supported by PDCB and downstream demand. — 140 KTPA
- Fuel additives capacity utilization will reach high levels in Q2FY27. — high levels, Q2FY27
- Energy and non-energy volumes will recover in Q2FY27. — Q2FY27
- FY28 EBITDA aspiration of ₹1,800 Crore remains intact for Aarti Industries despite Zone 4 delay. — ₹1,800 Crore, FY28
- [Aarti Industries] will not undertake further fuel additives capacity expansion until good utilization of the current 360 KTPA capacity is demonstrated over the next 12 months. — FY28
- [Aarti Industries] expects to regain Middle East market volumes in the upcoming quarters by opening new fronts for supply. — upcoming quarters
- Capex intensity will reduce significantly starting next year (FY28) for Aarti Industries. — FY28
- Aarti Industries will set up a subsidiary in China to expand market presence and enhance sourcing capabilities.
Key themes
Diversification push and capex delays amid macro headwinds
How the narrative shifted
- Capacity expansion and capex cycle peaking: Management stresses major capex is nearing completion, with Zone 4 phased commissioning and capex intensity reducing from FY28, positioning for growth despite execution delays.
- Geopolitical disruption and geographic diversification: The Middle East conflict reduced energy exports to 2% of revenue, but successful diversion to other markets and well-balanced geographic mix demonstrate resilience.
- Margin resilience via product mix and inventory gains: EBITDA surged 79% YoY aided by product mix optimization and low-cost inventory monetization, but management cautions that margin sustainability is tied to macro stability.
- Fuel additives market development and portfolio broadening: Fuel additives capacity reached 360 KTPA, and the company is expanding beyond MMA into a multi-product portfolio (3-5 new products) to drive long-term growth.
- NCB chain tailwinds from China VAT removal: Suspension of export tax rebates in China has created favorable pricing for NCB value chain, boosting margins in pharma and dyes segments.
- JV execution and new growth platforms: Augene JV commissioning on track, PEDA nearing commercialisation, plastic recycling JV in H2 FY27, and China subsidiary planned to accelerate market access and sourcing.
- Working capital and debt pressures: Higher feedstock prices and rising export volumes expanded working capital, driving up debt and finance costs, which management acknowledged but did not quantify a timeline for normalization.
- Mixed end-market demand with Q2 recovery expectations: Polymers and dyes segments saw soft demand due to high raw material prices and seasonal weakness, but management expects volume recovery across both energy and non-energy in Q2.
Operational commentary
- Fuel additives capacity expanded to 360 KTPA; Middle East revenue share dropped from 15% to 2% due to conflict, but volumes successfully diverted to other geographies; management expects high utilization in Q2.
- Zone 4 project delayed 3-6 months due to labour shortages; multipurpose plant and calcium chloride unit commissioning on track, but 5 chemistry blocks face slower ramp-up over FY28-29.
- Augene JV with Superform: commissioning in Q2FY27, first RM sale completed; steady-state revenue ₹300-400 Cr, PAT contribution expected in 2-4 quarters.
- PEDA project in market seeding and nearing commercialization; DCB debottlenecking to 140 KTPA planned.
- China subsidiary planned to expand market presence and enhance sourcing capabilities.
- NCB value chain margins improved after China's removal of export tax rebates; polymer demand soft in Q1, recovery expected Q2; dyes and pigments subdued due to high RM prices; agro volumes slightly lower.
- Gasoline-naphtha cracks averaged $15-20/bbl, supporting robust fuel additive demand.
Analyst Q&A
Q. How confident are you in reaching the lower end of FY28 EBITDA guidance given the 3-6 months Zone 4 delay?
Management acknowledged that the 5 chemistry blocks will see slower ramp-up than originally anticipated, but JVs, MPP and calcium chloride unit remain on track; they will share ramp-up details once they have a better understanding of the speed of the 5 blocks.
Q. Details on fuel additives new products beyond MMA, product names and count?
Management declined to name the products at this stage, stating they are in early sales efforts, but mentioned the pipeline includes 3-5 products falling into fuel additives broadly.
Q. Should we expect EBITDA run rate to revert to Q4 levels given large inventory and forex gains this quarter?
Management said volume growth could compensate for absence of inventory gains but margins remain dependent on macro and West Asia situation; they hesitated to give a run rate.
Q. What is a reasonable EBITDA number for next quarter given the one-off benefits in Q1?
Management stated it is not far away but explained that inventory gains might be compensated by volume growth, while margins are dependent on raw material price movements.
Research and educational content only. Not investment advice.